S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.02 (-1.75%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.02 (-1.75%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.02 (-1.75%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.02 (-1.75%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)
NYSE:NAPA

Duckhorn Portfolio (NAPA) Stock Price, News & Analysis

$8.17
+0.18 (+2.25%)
(As of 02:21 PM ET)
Today's Range
$8.00
$8.18
50-Day Range
$7.99
$9.64
52-Week Range
$7.78
$15.37
Volume
529,477 shs
Average Volume
1.11 million shs
Market Capitalization
$942.90 million
P/E Ratio
14.33
Dividend Yield
N/A
Price Target
$12.94

Duckhorn Portfolio MarketRank™ Stock Analysis

Analyst Rating
Hold
2.43 Rating Score
Upside/​Downside
58.9% Upside
$12.94 Price Target
Short Interest
Bearish
9.52% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.04mentions of Duckhorn Portfolio in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$498,706 Sold Last Quarter
Proj. Earnings Growth
11.86%
From $0.59 to $0.66 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.47 out of 5 stars

Consumer Staples Sector

90th out of 136 stocks

Beverages Industry

7th out of 12 stocks

NAPA stock logo

About Duckhorn Portfolio Stock (NYSE:NAPA)

The Duckhorn Portfolio, Inc. produces and sells wines in North America. The company offers wines under a portfolio of brands, including Duckhorn Vineyards, Decoy, Goldeneye, Paraduxx, Migration, Canvasback, Calera, Kosta Browne, Greenwing, and Postmark. It sells wines to distributors, and directly to retail accounts and consumers. The company was formerly known as Mallard Intermediate, Inc. and changed its name to The Duckhorn Portfolio, Inc. in February 2021. The company was founded in 1976 and is headquartered in Saint Helena, California. The Duckhorn Portfolio, Inc. is a subsidiary of Mallard Holdco, LLC.

NAPA Stock Price History

NAPA Stock News Headlines

Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
15 Best Wines To Buy At Costco According to Reddit
Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
Q2 2024 Duckhorn Portfolio Inc Earnings Call
Recap: Duckhorn Portfolio Q2 Earnings
Duckhorn (NYSE:NAPA) Misses Q2 Sales Targets
Barclays Keeps Their Buy Rating on Duckhorn Portfolio (NAPA)
See More Headlines
Receive NAPA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Duckhorn Portfolio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/07/2024
Today
4/19/2024
Next Earnings (Estimated)
6/13/2024
Fiscal Year End
7/31/2024

Industry, Sector and Symbol

Industry
Beverages
Sub-Industry
N/A
Fax
N/A
Employees
470
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.94
High Stock Price Target
$19.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+61.9%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
7 Analysts

Profitability

Net Income
$69.30 million
Pretax Margin
22.79%

Debt

Sales & Book Value

Annual Sales
$403 million
Cash Flow
$0.86 per share
Book Value
$8.17 per share

Miscellaneous

Free Float
113,909,000
Market Cap
$922.13 million
Optionable
Optionable
Beta
0.25
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

NAPA Stock Analysis - Frequently Asked Questions

Should I buy or sell Duckhorn Portfolio stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Duckhorn Portfolio in the last year. There are currently 1 sell rating, 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NAPA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NAPA, but not buy additional shares or sell existing shares.
View NAPA analyst ratings
or view top-rated stocks.

What is Duckhorn Portfolio's stock price target for 2024?

7 analysts have issued 1 year price targets for Duckhorn Portfolio's stock. Their NAPA share price targets range from $8.00 to $19.00. On average, they predict the company's share price to reach $12.94 in the next year. This suggests a possible upside of 58.9% from the stock's current price.
View analysts price targets for NAPA
or view top-rated stocks among Wall Street analysts.

How have NAPA shares performed in 2024?

Duckhorn Portfolio's stock was trading at $9.85 at the start of the year. Since then, NAPA shares have decreased by 17.4% and is now trading at $8.14.
View the best growth stocks for 2024 here
.

When is Duckhorn Portfolio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 13th 2024.
View our NAPA earnings forecast
.

How were Duckhorn Portfolio's earnings last quarter?

The Duckhorn Portfolio, Inc. (NYSE:NAPA) issued its earnings results on Thursday, March, 7th. The company reported $0.17 EPS for the quarter, meeting the consensus estimate of $0.17. The company earned $103.05 million during the quarter, compared to the consensus estimate of $106.38 million. Duckhorn Portfolio had a trailing twelve-month return on equity of 7.27% and a net margin of 16.62%. During the same quarter last year, the business posted $0.17 earnings per share.

What ETFs hold Duckhorn Portfolio's stock?

ETFs with the largest weight of Duckhorn Portfolio (NYSE:NAPA) stock in their portfolio include B.A.D. Etf (BAD).AdvisorShares Vice ETF (VICE).

What guidance has Duckhorn Portfolio issued on next quarter's earnings?

Duckhorn Portfolio updated its FY 2024 earnings guidance on Thursday, March, 7th. The company provided earnings per share guidance of 0.630-0.650 for the period, compared to the consensus estimate of 0.660. The company issued revenue guidance of $395.0 million-$411.0 million, compared to the consensus revenue estimate of $420.7 million.

When did Duckhorn Portfolio IPO?

Duckhorn Portfolio (NAPA) raised $300 million in an initial public offering (IPO) on Thursday, March 18th 2021. The company issued 20,000,000 shares at a price of $14.00-$16.00 per share. J.P.Morgan, Credit Suisse and Jefferies acted as the underwriters for the IPO and Barclays, BofA Securities, Citigroup, Evercore ISI, RBC Capital Markets, Academy Securities, Ramirez & Co. and Siebert Williams Shank were co-managers.

Who are Duckhorn Portfolio's major shareholders?

Duckhorn Portfolio's stock is owned by a number of retail and institutional investors. Top institutional investors include Allspring Global Investments Holdings LLC (0.02%). Insiders that own company stock include Alex Ryan, Carol Reber, Deirdre Mahlan, Lori Beaudoin, Mallard Holdco, Llc, Pete Przybylinski, Sean BA Sullivan and Zach Rasmuson.
View institutional ownership trends
.

How do I buy shares of Duckhorn Portfolio?

Shares of NAPA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NAPA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners